More than 2.4 million people in Azerbaijan have received two doses of a COVID-19 vaccine as of Friday, the Operative Headquarters under Azerbaijan’s Cabinet of Ministers said.
The total number of vaccine doses that have been given to people in Azerbaijan since January 18, 2021, when the first dose was administered in the country, amounted to 6 million. So far, 3.6 million people have had a first vaccine dose, and 2.4 million have had both doses.
Different types of COVID-19 vaccines have been authorized in Azerbaijan so far, including CoronaVac, Vaxzevria (formerly AstraZeneca), Sputnik V, and Pfizer-BioNTech. Residents can register for the vaccination via an online platform launched by the state-run Agency for Compulsory Health Insurance. The selection of the vaccine and the venue for inoculation is voluntary.
A vaccination “passport” is issued to all those fully vaccinated against the SARS-CoV-2, enabling holders to prove they have been inoculated.
Most of the vaccinated people has received the Chinese-made CoronaVac vaccine. Azerbaijan purchased a total of 9 million doses of CoronaVac confirmed to be 92 percent effective.
At the same time, 84,000 doses of British-Swedish Vaxzevria (formerly AstraZeneca) vaccines were supplied from South Korea to Azerbaijan within the COVAX initiative. A total of 432,000 jabs of Vaxzevria were expected to be delivered to Azerbaijan.
Azerbaijan also imported 80,000 jabs of Russia-made Sputnik V as part of the purchase agreement signed between the country’s government and the manufacturer in March. The overall number of Sputnik V jabs to be delivered to the country is 300,000. Azerbaijan also purchased 218,000 shots of the German-American Pfizer-BioNTech.
The inoculation of the country’s population will continue in line with the Vaccination Strategy against COVID-19 in Azerbaijan for 2021-2022.
COVID-19 has infected 384,886 and killed 5,252 people in Azerbaijan as of August 20. Currently, there are 36,227 active coronavirus cases in the country.